Загрузка...
Strategy and Efficacy of Generic and Pan-genotypic Sofosbuvir/Velpatasvir in Chronic Hepatitis C Virus: A Myanmar Experience
BACKGROUND: In resource-constrained areas, generic direct-acting antivirals (DAAs) have considerably reduced the cost of hepatitis C virus (HCV) therapy while there remain significant costs related to the baseline and follow-up virologic assays. AIM: The aim was to assess the efficacy and safety of...
Сохранить в:
| Опубликовано в: : | J Clin Exp Hepatol |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6637231/ https://ncbi.nlm.nih.gov/pubmed/31360020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.12.001 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|